Business Standard

Vaccinating the world means solving patent impasse; India has suggestion

A patent gives a drugmaker exclusive rights to manufacture a vaccine it developed

According to Oxfam, nine out of 10 people in underdeveloped countries will miss out on a vaccine in 2021. Photographer: Prashanth Vishwanathan/Bloomberg
Premium

According to Oxfam, nine out of 10 people in underdeveloped countries will miss out on a vaccine in 2021. Photographer: Prashanth Vishwanathan/Bloomberg

Hugo Miller and Susan Decker | Bloomberg
Covid-19 vaccines look set to protect millions of citizens of the world’s richest countries in the coming months. But inoculating the rest of the planet’s population may mean finding a way around an impasse over intellectual property.
 
Representatives from all 164 member states of the World Trade Organization met last week in Geneva to discuss a proposal from India and South Africa to waive broad sections of the WTO’s intellectual property rules and to try to forge an agreement on how patents developed in the race against Covid-19 should be recognized.

The meeting ended without consensus, leaving

What you get on BS Premium?

  • Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
  • Pick your 5 favourite companies, get a daily email with all news updates on them.
  • Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
  • Preferential invites to Business Standard events.
  • Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.
VIEW ALL FAQs

Need More Information - write to us at assist@bsmail.in